News
4d
PsyPost on MSNALS breakthrough: Ashwagandha-derived drug shows promise in slowing progression of amyotrophic lateral sclerosisEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...
"We are now trying also to extend our investigation, to investigate the role of viral infection in other neurodegenerative ...
Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results